-
Gene Therapy Development
- Gene Therapy Development
-
Gene Therapy Development
- Gene Therapy Development
Which are the best strategies to reduce costs while maintaining quality? Which are the advances in p ... -
C & G Bioprocessing
- C & G Bioprocessing
Process design and improvement. Phase appropriate: process and assay GMP perspective and CDMO/in hou ... -
Cell & Gene Manufacturing
- C & G Manufacturing
-
- C & G Bioprocessing
- C & G Manufacturing
- Cell Therapy Development
- Gene Therapy Development
Afternoon Refreshments -
- C & G Bioprocessing
- C & G Manufacturing
- Cell Therapy Development
- Gene Therapy Development
Morning Refreshments -
C & G Manufacturing
- C & G Manufacturing
How can manufacturers build an effective potency assurance strategy to guarantee the consistency and ... -
- C & G Bioprocessing
- C & G Manufacturing
- Cell Therapy Development
- Gene Therapy Development
Evening Drinks Reception -
C & G Bioprocessing
- C & G Bioprocessing
![Comparative Analysis of T-Cell Expansion by Bioreactor Type: Impacts on Process Metrics and Cell Quality [Topic TBC]](https://cdn.asp.events/CLIENT_HubXchan_638DBA0F_0C6E_8D3C_A444829FC0C4B73E/sites/HubXChange/media/libraries/partners/Terumo-BTC.png/fit-in/500x9999/filters:no_upscale())
The device used to manufacture an immunotherapeutic agent is a highly relevant factor in ensuring the most optimal product in terms of the time it takes to produce a dose of the therapy, the risk encountered in processing, and the final quality of that product. Three types of devices for T cell expansion were compared: a static culture perfusion membrane platform (SCPM), a rocking bag device (RB), and two sizes of hollow-fiber perfusion bioreactor (HFB-Large and HFB-Small). The T cell yield, time to dose, fold-expansion (FE), open events (OE), and Hands on Time (HoT) required for each device were measured.
-
Gene Therapy Development
- Gene Therapy Development
-
- C & G Bioprocessing
- C & G Manufacturing
- Cell Therapy Development
- Gene Therapy Development
1-2-1 Meetings / Networking Break -
- C & G Bioprocessing
- C & G Manufacturing
- Cell Therapy Development
- Gene Therapy Development
-
- C & G Bioprocessing
- C & G Manufacturing
- Cell Therapy Development
- Gene Therapy Development
1-2-1 Meetings / Networking Break -
- C & G Bioprocessing
- C & G Manufacturing
- Cell Therapy Development
- Gene Therapy Development
Networking Lunch -
C & G Bioprocessing
- C & G Bioprocessing
-
Gene Therapy Development
- Gene Therapy Development
-
Cell Therapy Development
- Cell Therapy Development
-
- C & G Bioprocessing
- C & G Manufacturing
- Cell Therapy Development
- Gene Therapy Development
1-2-1 Meetings / Networking Break -
- C & G Bioprocessing
- C & G Manufacturing
- Cell Therapy Development
- Gene Therapy Development
1-2-1 Meetings / Networking Break -
C & G Manufacturing
- C & G Manufacturing
How can manufacturers develop an effective potency assurance strategy to guarantee the consistency a ... -
C & G Bioprocessing
- C & G Bioprocessing
How can early process designs evaluate scalability and incorporate technology to support growing dem ... -
Cell Therapy Development
- Cell Therapy Development
How to develop stealth mechanisms to enhance the persistence of allogeneic therapies, including iPSC ... -
- C & G Bioprocessing
- C & G Manufacturing
- Cell Therapy Development
- Gene Therapy Development
)
-
- C & G Bioprocessing
- C & G Manufacturing
- Cell Therapy Development
- Gene Therapy Development
Registration
Advanced Therapies Xchange - San Diego - 2025
)
)
)
)
)
)
)
)